Regeneron Pharmaceuticals
REGN
#230
Rank
ยฃ72.80 B
Marketcap
ยฃ703.79
Share price
-0.19%
Change (1 day)
24.95%
Change (1 year)

Market capitalization of Regeneron Pharmaceuticals (REGN)

Market cap: ยฃ72.80 Billion

As of November 2026 Regeneron Pharmaceuticals has a market cap of ยฃ72.80 Billion. This makes Regeneron Pharmaceuticals the world's 230th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Regeneron Pharmaceuticals from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ72.80 B17.85%
2025ยฃ61.77 B-0.97%
2024ยฃ62.38 B-16.94%
2023ยฃ75.10 B15.65%
2022ยฃ64.94 B29.08%
2021ยฃ50.31 B33.04%
2020ยฃ37.81 B19.77%
2019ยฃ31.57 B-1.55%
2018ยฃ32.07 B7.32%
2017ยฃ29.88 B-4.75%
2016ยฃ31.37 B-18.15%
2015ยฃ38.33 B42.03%
2014ยฃ26.99 B62.26%
2013ยฃ16.63 B61.53%
2012ยฃ10.29 B211.91%
2011ยฃ3.30 B73.61%
2010ยฃ1.90 B56.92%
2009ยฃ1.21 B21.46%
2008ยฃ0.99 B4.09%
2007ยฃ0.95 B43.04%
2006ยฃ0.67 B28.77%
2005ยฃ0.52 B94.19%
2004ยฃ0.26 B-41.35%
2003ยฃ0.45 B-11.06%
2002ยฃ0.51 B-39.83%
2001ยฃ0.85 B-1.78%
2000ยฃ0.86 B250.62%
1999ยฃ0.24 B80.23%
1998ยฃ0.13 B-14.65%
1997ยฃ0.16 B-33.34%
1996ยฃ0.24 B

End of Day market cap according to different sources

On Nov 20th, 2026 the market cap of Regeneron Pharmaceuticals was reported to be:

ยฃ72.80 Billion
by Nasdaq info icon info icon
ยฃ72.80 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
ยฃ497.71 B 583.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ217.23 B 198.37%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
ยฃ180.12 B 147.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ85.38 B 17.28%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
ยฃ28.20 B-61.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ14.72 B-79.78%๐Ÿ‡บ๐Ÿ‡ธ USA